Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Direxion Daily S&P 500 Bear 3X Shares ETF
SPXS
5
ProShares UltraPro Short S&P500 ETF
SPXU
US Stock MarketDetailed Quotes
MED Medifast
- 13.250
- +0.270+2.08%
Close May 2 16:00 ET
- 13.250
- 0.0000.00%
Post 16:05 ET
145.63MMarket Cap-20.70P/E (TTM)
13.500High12.815Low266.32KVolume13.000Open12.980Pre Close3.53MTurnover2.71%Turnover Ratio69.74P/E (Static)10.99MShares27.18052wk High0.69P/B130.20MFloat Cap11.56952wk Low--Dividend TTM9.83MShs Float298.463Historical High--Div YieldTTM5.28%Amplitude-1.875Historical Low13.266Avg Price1Lot Size
Medifast Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -53.23%3.41M | -83.42%24.48M | -147.02%-4.95M | -69.69%9.07M | -69.71%13.07M | -88.63%7.28M | -24.11%147.66M | -79.66%10.52M | -45.97%29.93M | -1.41%43.15M |
| Net income from continuing operations | -109.28%-772K | -97.90%2.09M | -86.73%801K | -95.13%1.13M | -126.93%-8.15M | -79.19%8.32M | -30.75%99.42M | -77.24%6.04M | -36.02%23.13M | -22.58%30.28M |
| Operating gains losses | 9,400.00%380K | -100.51%-6K | -95.45%25K | -366.67%-8K | ---27K | --4K | -44.98%1.17M | --550K | --3K | ---- |
| Depreciation and amortization | 0.58%3.28M | -3.05%12.71M | -5.01%3.19M | -6.39%3.19M | -8.94%3.07M | 9.65%3.26M | 19.37%13.11M | 13.51%3.35M | 19.72%3.41M | 23.28%3.37M |
| Deferred tax | -82.14%20K | -711.31%-7.4M | -212.08%-7.52M | 101.68%106K | ---103K | -86.00%112K | 231.06%1.21M | 716.06%6.71M | -260.65%-6.3M | --0 |
| Other non cash items | 3.34%1.15M | 251.18%16.18M | 5.86%1.14M | 10.61%1.13M | 1,018.52%12.81M | -19.07%1.11M | -24.45%4.61M | -20.84%1.08M | -33.42%1.02M | -28.08%1.15M |
| Change In working capital | 65.09%-1.77M | -148.06%-9.75M | 47.42%-4.88M | -80.34%1.18M | -118.85%-984K | -127.60%-5.06M | -6.35%20.28M | -161.79%-9.27M | -56.12%5.99M | 305.27%5.22M |
| -Change in inventory | -63.25%3.06M | -81.06%12.17M | -163.97%-2.33M | -104.61%-492K | -76.18%6.67M | -62.12%8.32M | 5.03%64.27M | -86.24%3.64M | -8.77%10.67M | -12.49%28M |
| -Change in prepaid assets | 109.84%73K | -55.61%2.47M | 36.88%-1.5M | 36.81%5.78M | 62.46%-1.07M | -111.31%-742K | 5,639.18%5.57M | -32.87%-2.38M | 86.62%4.23M | 18.40%-2.84M |
| -Change in payables and accrued expense | 61.65%-4.86M | 2.00%-34.99M | -766.00%-11.72M | 39.69%-3.85M | 63.77%-6.77M | -36.24%-12.66M | 5.02%-35.71M | 91.61%-1.35M | -10,728.33%-6.38M | 36.71%-18.68M |
| -Change in other current assets | -270.83%-41K | 108.44%396K | 2,390.00%458K | 89.42%-268K | 114.50%182K | 102.71%24K | -37.57%-4.69M | -100.39%-20K | -573.40%-2.53M | 18.35%-1.26M |
| -Change in other working capital | ---- | 211.55%10.21M | ---- | ---- | ---- | ---- | -766.79%-9.16M | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -53.23%3.41M | -83.42%24.48M | -147.02%-4.95M | -69.69%9.07M | -69.71%13.07M | -88.63%7.28M | -24.11%147.66M | -79.66%10.52M | -45.97%29.93M | -1.41%43.15M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 25.98%-2.05M | 56.56%-26.52M | -81.07%-19.43M | 96.16%-1.78M | -45.18%-2.53M | -31.21%-2.78M | -434.84%-61.05M | -18.39%-10.73M | -2,527.66%-46.46M | -247.55%-1.74M |
| Net PPE purchase and sale | 17.33%-1.52M | -14.98%-7.45M | -141.54%-2.29M | 17.16%-1.39M | -11.12%-1.94M | 12.96%-1.84M | 61.14%-6.48M | 89.56%-946K | 5.09%-1.68M | 38.59%-1.74M |
| Net investment purchase and sale | 43.04%-532K | 65.06%-19.07M | -75.23%-17.15M | 99.12%-392K | ---594K | ---934K | -1,135.96%-54.56M | ---9.79M | ---44.78M | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 25.98%-2.05M | 56.56%-26.52M | -81.07%-19.43M | 96.16%-1.78M | -45.18%-2.53M | -31.21%-2.78M | -434.84%-61.05M | -18.39%-10.73M | -2,527.66%-46.46M | -247.55%-1.74M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 62.24%-563K | 98.10%-1.52M | 99.99%-1K | 99.98%-3K | 99.89%-20K | 94.24%-1.49M | 60.02%-79.79M | 26.41%-17.91M | 59.75%-18.15M | 82.52%-17.84M |
| Net common stock issuance | 54.83%-369K | 87.99%-836K | 90.00%-1K | 98.18%-2K | -700.00%-16K | 88.05%-817K | 94.56%-6.96M | 99.84%-10K | -340.00%-110K | 100.00%-2K |
| Cash dividends paid | 72.68%-194K | 99.02%-715K | --0 | 99.99%-1K | 99.98%-4K | 96.29%-710K | -1.95%-73.02M | -0.31%-17.98M | 0.21%-18.04M | 5.93%-17.83M |
| Proceeds from stock option exercised by employees | --0 | -80.85%36K | --0 | --0 | --0 | -65.71%36K | --188K | --83K | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 62.24%-563K | 98.10%-1.52M | 99.99%-1K | 99.98%-3K | 99.89%-20K | 94.24%-1.49M | 60.02%-79.79M | 26.41%-17.91M | 59.75%-18.15M | 82.52%-17.84M |
| Net cash flow | ||||||||||
| Beginning cash position | -3.72%90.93M | 7.70%94.44M | 2.27%115.31M | -26.72%108.02M | -21.23%97.47M | 7.70%94.44M | -15.83%87.69M | 61.74%112.75M | 141.37%147.41M | 4.87%123.75M |
| Current changes in cash | -73.84%789K | -152.18%-3.56M | -34.59%-24.38M | 121.01%7.29M | -55.37%10.52M | -91.63%3.02M | 141.53%6.82M | -198.75%-18.11M | -506.95%-34.68M | 141.29%23.57M |
| Effect of exchange rate changes | --0 | 165.28%47K | --0 | -84.62%4K | -68.89%28K | 66.67%15K | -7.46%-72K | 45.73%-197K | -78.15%26K | -38.78%90K |
| End cash Position | -5.90%91.72M | -3.72%90.93M | -3.72%90.93M | 2.27%115.31M | -26.72%108.02M | -21.23%97.47M | 7.70%94.44M | 7.70%94.44M | 61.74%112.75M | 141.37%147.41M |
| Free cash flow | -65.37%1.88M | -87.94%17.02M | -175.52%-7.23M | -72.81%7.68M | -73.11%11.13M | -91.22%5.44M | -20.64%141.17M | -77.56%9.58M | -47.32%28.25M | 1.17%41.4M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
